The Spinosad Topical Suspension 0.9% formulation was designed to drive spinosad to the site of the infestation.1

Delivers the active compound (spinosad) to the stratum corneum

When applied on the outer layer of the epidermis,:

  • Spinosad Topical Suspension 0.9% liquefies at body temperature1
  • The active compound (spinosad) sloughs off through a natural process of non-pathologic desquamation (over approximately 14 days)3

Spinosad Topical Suspension 0.9% MOA defines targeted topical therapy:1

  • Spinosad, the active compound, does not penetrate into the dermis or enter into the systemic circulation, and is therefore not absorbed systemically in the lipids of major organs, including the brain, heart, lungs, kidneys, and liver
  • There is no prolonged prevalence of the the active compound, spinosad
  • There are no concerns regarding the speed of drug metabolism for the active compound, spinosad